Name: ROCHE HOLDING AG-BR (RHO) Stock
Brand: ROCHE HOLDING AG-BR
Rating: 6.5 (3 reviews)

Question 1

Can you describe the business of ROCHE HOLDING AG-BR?

Accepted Answer

Roche Holding AG is a research healthcare company. The company is headquartered in Basel, Basel-Stadt and currently employs 103,249 full-time employees. The company went IPO on 2001-05-04. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Question 2

Can you provide the latest stock price for ROCHE HOLDING AG-BR?

Accepted Answer

The current stock price of RHO.DE is 362.6 EUR. The price increased by 1.63% in the last trading session.

Question 3

Does ROCHE HOLDING AG-BR pay dividends?

Accepted Answer

ROCHE HOLDING AG-BR (RHO.DE) has a dividend yield of 2.94%. The yearly dividend amount is currently 10.88.

Question 4

How is the ChartMill rating for ROCHE HOLDING AG-BR?

Accepted Answer

RHO.DE has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 6 out of 10.

Question 5

What is the GICS sector and industry of RHO stock?

Accepted Answer

ROCHE HOLDING AG-BR (RHO.DE) operates in the Health Care sector and the Pharmaceuticals industry.

Question 6

Can you provide the PE ratio for RHO stock?

Accepted Answer

The PE ratio for ROCHE HOLDING AG-BR (RHO.DE) is 17.11. This is based on the reported non-GAAP earnings per share of 21.19 and the current share price of 362.6 EUR.

Question 7

Can you provide the market cap for ROCHE HOLDING AG-BR?

Accepted Answer

ROCHE HOLDING AG-BR (RHO.DE) has a market capitalization of 293.43B EUR. This makes RHO.DE a Mega Cap stock.

ROCHE HOLDING AG-BR (RHO.DE) Stock Price, Forecast & Analysis

RHO.DE Latest News, Press Relases and Analysis